BioMS Medical Corp (TSX: MS), a leading
developer in the treatment of multiple sclerosis (MS), announces that its
Board of Directors has adopted a shareholder rights plan designed to encourage
the fair treatment of shareholders in connection with any take-over offer for
the Corporation. The plan was not adopted in response to an anticipated
takeover bid, but as a general planning measure.
